This inventor holds 3 USPTO granted patents. Top assignees: Burroughs Wellcome Co., The Wellcome Foundation Limited. Active years: 1983-1985.
Company Filing History:
Years Active: 1983-1985
Title: George W Hardy: Innovator in Pharmaceutical Peptides
Introduction
George W Hardy is a notable inventor based in Biggin Hill, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides and amides. With a total of 3 patents, his work has had a considerable impact on medical therapy.
Latest Patents
Hardy's latest patents include innovative compounds that exhibit enkephalinase inhibitory activity. One of his patents focuses on pharmaceutical peptides, detailing their preparation, use, and intermediates. These peptides are characterized by a specific formula where R¹ can be hydrogen, alkyl of 1 or 2 carbon atoms, or an amidino group. Another patent involves pharmaceutical amides, which are compounds with a general formula that includes various substituents such as halo, alkyl, amino, and more. These compounds are designed to enhance the effects of endogenous or exogenous enkephalins, making them valuable in medical applications.
Career Highlights
Throughout his career, Hardy has worked with prominent companies in the pharmaceutical industry, including Burroughs Wellcome Co. and The Wellcome Foundation Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Hardy has collaborated with notable individuals in his field, including Samuel Wilkinson and Lawrence Alfred Lowe. These partnerships have likely enriched his research and development efforts.
Conclusion
George W Hardy's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence medical therapies and advancements in pharmaceuticals.